Company · CIK 0001395064 · SIC 2834 — Pharmaceutical Preparations · NYSE
TAKEDA PHARMACEUTICAL CO LTD · TAK
Insider activity reported against this company. All insider holders · Files at: MYOV, MTEM. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 SForm 4 → | Sep 15, 9:12 pm EDT | Lauren Rusckowski DupreyChief Transformation Officer | 34,535 | $18.54 | $640,279 | 191,522 | −15.3% | |
| Sep 2, 2026 SForm 4 → | Sep 3, 9:49 pm EDT | Andrew Stewart PlumpPresident, R&D, Director | 116,191 | $18.49 | $2,148,372 | 145,465 | −44.4% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.